“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...

Dr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...

The 6-month room temperature stability on this batch adds to the nine-month data accumulated on a previous batch produced by ...

In a significant crackdown on illicit drug smuggling, the Keta Divisional Police Command in the Volta Region have arrested ...

Registration and reporting of clinical trial results required by FDA regulations Some studies are required to be registered at ClinicalTrials.gov in accordance with the federal regulations in Section ...

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...

The FDA and HHS announced "Operation Stork Speed" Tuesday, which aims to increase testing for heavy metals and other ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

The Food and Drug Administration (FDA) announced a new initiative Tuesday titled “Operation Stork Speed” aimed at reviewing ...

Somehow Washington regards the industry, which has saved and improved tens of millions of lives, as a villain.

FDA accepts Capricor's Biologics License Application for priority review, advancing deramiocel for DMD cardiomyopathy.